New Age Alpha Advisors, LLC Roivant Sciences Ltd. Transaction History
New Age Alpha Advisors, LLC
- $2.23 Trillion
- Q1 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 21,966 shares of ROIV stock, worth $251,510. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,966
Previous 16,023
37.09%
Holding current value
$251,510
Previous $190 Million
16.93%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$753 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$708 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$527 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$467 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$411 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.07B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...